05/14/2025
4:13 PM | FELDMAN STUART (Filed by)
Mural Oncology (Subject)
| Form SCHEDULE 13G | |
04/28/2025
7:00 AM | Mural Oncology (Filer)
| Form DEF 14A | |
04/28/2025
7:03 AM | Mural Oncology (Filer)
| Form DEFA14A | |
04/28/2025
7:06 AM | Mural Oncology (Filer)
| Form ARS | |
04/16/2025
4:37 PM | Mural Oncology (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
| Form SCHEDULE 13G | |
04/15/2025
7:06 AM | Mural Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2025
5:38 AM | Mural Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2025
3:56 PM | Mural Oncology (Filer)
| Form 424B5 | |
03/11/2025
3:58 PM | Mural Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
4:10 PM | Loew Caroline (Reporting)
Mural Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025
3:47 PM | Cutler Adam D. (Reporting)
Mural Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for MURA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Mural Oncology and its competitors with MarketBeat's FREE daily newsletter. |
03/05/2025
3:47 PM | Goodman Vicki L (Reporting)
Mural Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:48 PM | Loew Caroline (Reporting)
Mural Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
3:49 PM | Keson-Brookes Maiken (Reporting)
Mural Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/24/2025
3:11 PM | Goodman Vicki L (Reporting)
Mural Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025
11:18 AM | ACORN BIOVENTURES, L.P. (Filed by)
Mural Oncology (Subject)
| Form SCHEDULE 13G/A | |
01/10/2025
6:00 AM | Mural Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
3:19 PM | Keson-Brookes Maiken (Reporting)
Mural Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024
3:06 PM | Loew Caroline (Reporting)
Mural Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
11:15 PM | Mural Oncology (Filer)
| Form EFFECT | |
11/14/2024
2:18 PM | Mural Oncology (Subject)
Solas Capital Management, LLC (Filed by)
| Form SCHEDULE 13G | |
11/13/2024
3:06 PM | Mural Oncology (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/13/2024
6:04 AM | Mural Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2024
6:05 AM | Mural Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2024
2:52 PM | Mural Oncology (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/04/2024
1:39 PM | Mural Oncology (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/01/2024
6:04 AM | Cutler Adam D. (Reporting)
Mural Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/01/2024
6:08 AM | Cutler Adam D. (Reporting)
Mural Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/26/2024
6:30 AM | Mural Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
6:13 AM | Mural Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
3:15 PM | ALTSCHULLER Susan (Reporting)
Mural Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:43 PM | ACORN BIOVENTURES, L.P. (Filed by)
Mural Oncology (Subject)
| Form SCHEDULE 13G | |
08/13/2024
6:18 AM | Mural Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
6:19 AM | Mural Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
12:02 PM | Mural Oncology (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
| Form SC 13G/A | |
07/31/2024
3:02 PM | Golumbeski George (Reporting)
Mural Oncology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/31/2024
3:03 PM | Golumbeski George (Reporting)
Mural Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/31/2024
6:20 AM | Mural Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
3:04 PM | Keson-Brookes Maiken (Reporting)
Mural Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
8:42 PM | Mural Oncology (Subject)
WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
| Form SC 13G/A | |
07/08/2024
7:01 PM | Loew Caroline (Reporting)
Mural Oncology (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
07/08/2024
7:03 PM | Loew Caroline (Reporting)
Mural Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Mural Oncology (Subject)
| Form SC 13G/A | |
06/05/2024
3:10 PM | Jackson Scott Thomas (Reporting)
Mural Oncology (Issuer)
| Form 4/A | |
06/05/2024
3:13 PM | Cuss Francis M (Reporting)
Mural Oncology (Issuer)
| Form 4/A | |
06/05/2024
3:16 PM | Hickey Benjamin (Reporting)
Mural Oncology (Issuer)
| Form 4/A | |
06/03/2024
9:20 AM | Cuss Francis M (Reporting)
Mural Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
9:23 AM | Hickey Benjamin (Reporting)
Mural Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
9:11 AM | ALTSCHULLER Susan (Reporting)
Mural Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
9:14 AM | Jackson Scott Thomas (Reporting)
Mural Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Buy MURA Stock Free MURA Stock Alerts